Professional Documents
Culture Documents
Influenza A (H1N1) : Disampaikan Oleh DR Fermizet Rudy SPPD
Influenza A (H1N1) : Disampaikan Oleh DR Fermizet Rudy SPPD
Influenza A (H1N1) : Disampaikan Oleh DR Fermizet Rudy SPPD
Disampaikan
oleh
Dr FERMIZET RUDY SpPD
National Center for Disease Prevention and Control, DOH
Pandemics of
Recorded human
pandemic influenza
influenza
(early sub-types inferred)
H2N2
H2N2
H1N1
H1N1
H3N8
1895 1905
1889
Russian
influenza
H2N2
1915
1925
1900
Old Hong
Kong influenza
H3N8
1955
1918
Spanish
influenza
H1N1
1965
1957
Asian
influenza
H2N2
1975
1985
Reproduced and adapted (2009) with permission of Dr Masato Tashiro, Director, Center for Influenza Virus Research,
National Institute of Infectious Diseases (NIID), Japan.
1965
1975
1985
2005
2010
2009
Novel
influenza
H1N1v
H9*
H5
H7 1980
1955
1995
1968
Hong Kong
influenza
H3N2
H1N1v
H3N2
1999
1997 2003
1996
1995
2002
2005
2015
Influenza A reservoir
Wild aquatic birds are the main reservoir of influenza A viruses. Virus transmission has been reported from weild waterfowl to poultry, sea
mammals, pigs, horses, and humans. Viruses are also transmitted between pigs and humans, and from poultry to humans. Equine
influenza viruses have recently been transmitted to dogs. (From Fields Vriology (2007) 5th edition, Knipe, DM & Howley, PM, eds, Wolters
Kluwer/Lippincott Williams & Wilkins, Philadelphia, Fig 48.1)
Influenza A (H1N1)
Is PANDEMIC Imminent?
Transmission of Influenza
Limited studies, varying
interpretations
Contact, droplet, and droplet
nuclei (airborne) transmission all
likely occur
Relative contribution of each
unclear
Droplet thought most important
Coughing, sneezing, talking
Key Characteristics
Communicability
Viral shedding can begin 1
day before symptom onset
Peak shedding first 3 days
of illness
Correlates with
temperature
Subsides usually by 5-7th
day in adults
can be 10+ days in
children
Infants, children and the
immuno-compromised may
shed the virus longer
National Center for Disease Prevention and Control, DOH
Incubation period
Time from exposure to onset of
symptoms
1 to 4 days (average = 2 days)
Seasonality
In temperate zones, sharp peaks in winter
months
In tropical zones, circulates year-round
with seasonal increases.
Abrupt onset
Fever and constitutional symptoms: body aches,
headaches, fatigue
Cough, rhinitis, sore throat
GI symptoms and myositis more common in young
children
Sepsis-like syndrome in infants
Complications: viral and bacterial pneumonia,
febrile seizures, cardiomyopathy,
encephalopathy/encephalitis, worsening underlying
chronic conditions
Pregnant women
Vaccination
Influenza vaccine is the best prevention for
seasonal influenza.
Inactivated viruses in the vaccine developed
from three circulating strains (generally 2
Type A and 1 Type B strain)
Therefore, seasonal flu shot only works for 3
influenza subtypes and will not work on pandemic
strains.
Influenza Viruses
Classified into types A, B,
and C
Only Types A and B cause
significant disease
Types B and C limited to
humans
Type A viruses
More virulent
Affect many species
C Goldsmith, CDC
Influenza A Viruses
Influenza A viruses categorized by subtype
Classified according to two surface proteins
Hemagglutinin (H) 16 known
Site of attachment to host cells
Antibody to HA is protective
N
H
Influenza replication
Replication of influenza A virus. After binding (1) to sialic acid-containing receptors, influenza is endocytosed and fuses (2) with the vesicle
membrane. Unlike for most other RNA viruses, transcription (3) and replication (5) of the genome occur in the nucleus. Viral proteins are
synthesized (4), helical nucleocapsid segments form and associate (6) with the M1 protein-lined membranes containing M2 and the HA and NA
glycoproteins. The virus buds (7) from the plasma membrane with 11 nucleocapsid segments. (-), Negative sense; (+), positive sense; ER,
endoplasmic reticulum. (From Medical Microbiology, 5th ed., Murray, Rosenthal & Pfaller, Mosby Inc., 2005, Figure 60-2.)
Nomenclatur
e
Virus type
Strain number
Virus subtype
A / Sydney / 05 / 97 (H3N2)
Place virus
isolated
Year isolated
Influenza A (H1N1) is a
novel virus
Unusual combination of genetic
material from pigs, birds & humans
which have re-assorted
human-to-human transmission occurs
through respiratory droplets generated
from sneeze or cough
Affects all age groups
Vaccines for human seasonal flu can not
protect humans against the novel virus
National Center for Disease Prevention and Control, DOH
Genetic Re-assortment
SIV
Fever
Lethargy
Lack of appetite
Coughing
Runny Nose
Sore throat
Nausea / Vomiting
Diarrhea
National Center for Disease Prevention and Control, DOH
Cold
Onset
sudden
sub acute
Fever
Very high
rare
HA
severe
rare
Fatigue
extreme
mild
Myalgia
common
mild
Cough
Common
rare
Sore throat
Sometimes
common
Nasal sx
Sometimes
common
Complications
Lung, heart
Ear, sinus
Influenza pathogenesis
Pathogenesis of influenza A virus. The symptoms of influenza are caused by viral pathologic and immunopathologic effects, but the
infection may promote secondary bacterial infection. CNS, Central nervous system. (From Medical Microbiology, 5th ed., Murray,
Rosenthal & Pfaller, Mosby Inc., 2005, Figure 60-3.)
Transmission: Food-Borne?
NO
Influenza A (H1N1) viruses are not
transmitted through food
Safe to eat properly handled and
cooked pork and pork products
Cook pork at an internal temperature
of 70C (160F)
Treatment
Influenza A (H1N1) is sensitive to:
Oseltamivir (tamiflu)
Zanamivir
Vaccine
No Influenza A (H1N1) vaccine yet
Process of production is underway,
but may take 5 6 months
Seasonal influenza vaccine provides
protection against the seasonal
human influenza strains only